NCT06772701

Brief Summary

In recent years, fatherhood has changed considerably. Fathers are now more involved during the perinatal period, with their partner but also in caring for the child. Investigators now know that this period is also a source of major psychological upheaval, identity crisis, apprehension and anxiety for men. These upheavals can lead to depression that must be detected and treated as early as possible. This is an easy screening to perform using the EPDS (Edinburgh Postnatal Depression Scale). Currently, the EPDS is the most widely used self-questionnaire to assess the risk of depression in women during the perinatal period. Indeed, it is systematically recommended in many countries. It is starting to be used for the same purpose in the perinatal period in men, although the scale has not been validated in a representative sample of men in the pre- or post-natal period. The main objective is to validate the use of the EPDS scale as a screening tool for postnatal depression in a population of French fathers. They complete the PH-Q9, EPDS and socio-demographic questionnaires online at inclusion and 6 to 8 weeks after the birth of their child. Fathers included at the maternity ward also too Mini International Neuropsychiatric Interview (MINI) at inclusion.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,000

participants targeted

Target at P75+ for not_applicable

Timeline
10mo left

Started Jul 2024

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress68%
Jul 2024Mar 2027

Study Start

First participant enrolled

July 11, 2024

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

January 9, 2025

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 13, 2025

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 12, 2027

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 12, 2027

Last Updated

January 21, 2026

Status Verified

January 1, 2026

Enrollment Period

2.5 years

First QC Date

January 9, 2025

Last Update Submit

January 19, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Mini International Neuropsychiatric Interview

    This short structured clinical interview is used to diagnose psychiatric disorders and is currently the gold standard for diagnosing depression.

    at inclusion

Secondary Outcomes (1)

  • socio-demographic questionnaire

    at inclusion and 6 to 8 weeks after the birth of their child

Study Arms (2)

Fathers included at the maternity hospital or through their wife

ACTIVE COMPARATOR

At inclusion, fathers included at the maternity hospital or through their wife take the Mini International Neuropsychiatric Interview and complete the EPDS book (PH-Q9, EPDS and socio-demographic questionnaire). 6 to 8 weeks after the birth of their child, they complete only EPDS book.

Diagnostic Test: Mini International Neuropsychiatric InterviewOther: EPDS book

fathers includes through the awareness campaign

EXPERIMENTAL

At inclusion, fathers included through the awareness campaign have only the EPDS book (PH-Q9, EPDS and socio-demographic questionnaire) at inclusion. 6 to 8 weeks after the birth of their child, they complete the same EPDS book.

Other: EPDS book

Interventions

Fathers have Mini International Neuropsychiatric Interview, the standard diagnostic tool for post-natal depression

Fathers included at the maternity hospital or through their wife

PH-Q9, EPDS and socio-demographic questionnaires are completed online at inclusion and 6 to 8 weeks after the birth of child.

Fathers included at the maternity hospital or through their wifefathers includes through the awareness campaign

Eligibility Criteria

Age18 Years+
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All fathers whose baby is 10 days old or less

You may not qualify if:

  • People with a poor understanding of spoken or written French
  • Minors
  • Persons under court protection, guardianship or curatorship

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Antoine-Béclère hospital AP-HP

Clamart, 92140, France

ENROLLING BY INVITATION

Le Havre hospital - site Jacques Monod

Montivilliers, 76290, France

RECRUITING

MeSH Terms

Conditions

Depression, Postpartum

Condition Hierarchy (Ancestors)

Puerperal DisordersPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDepressive DisorderMood DisordersMental Disorders

Central Study Contacts

Angélique PICARD, project coordinator

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SCREENING
Intervention Model
PARALLEL
Model Details: Fathers included at the maternity hospital or through the mother take the Mini International Neuropsychiatric Interview and complete the PH-Q9, EPDS and socio-demographic questionnaires. Fathers included through the awareness campaign have only the PH-Q9, EPDS and socio-demographic questionnaires.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 9, 2025

First Posted

January 13, 2025

Study Start

July 11, 2024

Primary Completion (Estimated)

January 12, 2027

Study Completion (Estimated)

March 12, 2027

Last Updated

January 21, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations